BRLI:
Analysis & Opinions
-
December 06, 2012
The Nasdaq has increased 0.7%, the S&P 500 is up 0.3% and the Dow is trading up 0.3% on a good day for the market so ...
-
October 11, 2012
The morning has been good for the market. The Nasdaq has risen 0.3%; the S&P 500 is up 0.6%; and the Dow has climbed ...
-
October 05, 2012
The market has been doing well after the morning's trading. The Nasdaq has climbed 0.2%; the S&P 500 has increased ...
-
October 03, 2012
The Nasdaq is up 0.7%, the S&P 500 has climbed 0.5% and the Dow has moved up 0.3%, marking a bad morning for the ...
-
September 13, 2012
The Nasdaq has moved up 0.3%, the S&P 500 has increased 0.1% and the Dow has risen 0.2%, marking a bad morning for ...
-
September 11, 2012
The Nasdaq has increased 0.3%, the S&P 500 has risen 0.6% and the Dow has moved up 0.7% on a good day for the market ...
-
August 30, 2012
The market is currently down, with the Nasdaq slipping 0.9%, the S&P 500 down 0.7% and the Dow declining 0.7%. The ...
-
August 23, 2012
PSS World Medical, Inc. (PSSI), a medical supplies and equipment distributor to office-based physicians, recently ...
-
August 23, 2012
The market has been slipping so far today: the Nasdaq has decreased 0.2%; the S&P 500 has slipped 0.4%; and the Dow ...
-
August 23, 2012
The market is having a bad day so far. The Nasdaq has slipped 0.2%; the S&P 500 has decreased 0.4%; and the Dow is ...
-
June 22, 2012
The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects ...
-
April 24, 2012
LabCorp is feeling pressures from large health insurers and the government, but the company remains firmly ...
-
March 16, 2012
If you're interested in looking beyond blue-chip growth stocks, consider these sector leaders that pack a lot of ...
-
August 30, 2011
Bio Reference Labs' earnings multiple is rather reasonable given the growth it has been posting.
-
July 28, 2011
LabCorp's valuation is quite reasonable but cash flow growth remains an issue.
-
January 26, 2011
Novartis takes another step into molecular diagnostics.
-
September 14, 2010
Genzyme and Lab Corp. forge a rare win-win deal in the lab space.
-
April 19, 2010
Individual investors may want to wait on the sidelines for sales visibility to improve and for higher levels of ...
